CompanyTrack
Sign Up Log In
D

DARK BLUE THERAPEUTICS LTD

Active Oxford

Research and experimental development on biotechnology

13 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
D

DARK BLUE THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 4 Jun 2020 Active Oxford, United Kingdom 13 employees darkbluetx.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 22 Jan 2025
Confirmation Statement Submitted 5 Jun 2025
Net assets £11.47M £12.19M 2024 year on year
Total assets £12.31M £3.99M 2024 year on year
Total Liabilities £834.49K £8.20M 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Hayakawa Building, Edmund Halley Road The Oxford Science Park Oxford OX4 4GB United Kingdom

Telephone

0186 580 3112

Credit Report

Discover DARK BLUE THERAPEUTICS LTD's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£11.66M

Increased by £3.97M (+52%)

Net Assets

£11.47M

Increased by £12.19M (+1693%)

Total Liabilities

£834.49k

Decreased by £8.20M (-91%)

Turnover

N/A

Employees

13

Increased by 6 (+86%)

Debt Ratio

7%

Decreased by 102 (-94%)
See 10 Year Full Financials

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 120,051,434 Shares £2341.47m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Apr 20252,898,689£289.869£0
6 Mar 20251,262,695£126.27£0
28 Jun 202455,000,000£11.00m£0.2
22 Mar 202419,913,560£7.97m£0.4
1 Nov 202340,000£4£0

Officers

Officers

6 active 6 resigned
Status
Alastair Graham MackinnonDirectorBritishEngland558 Aug 2022Active
Edwin MosesDirectorBritish,belgianBelgium7117 Mar 2025Active
Emma SmithSecretaryUnknownUnknown—9 Mar 2023Active
James CarmichaelDirectorBritishUnited Kingdom7524 Jul 2020Active
Justian Craig FoxDirectorBritishEngland5016 May 2024Active
Thomas HankeDirectorGermanGermany6124 Jul 2020Active

Shareholders

Shareholders (29)

The Chancellor, Masters And Scholars Of The University Of Oxford
1.3%
1,593,7505 Jun 2025
Thomas Milne
0.3%
300,0005 Jun 2025
The Chancellor. Masters And Scholars Of The University Of Oxford
0.0%
10,6255 Jun 2025

Persons with Significant Control

Persons with Significant Control (2)

2 Active 3 Ceased

Oxford Science Enterprises Plc

United Kingdom

Active
Notified 28 Jun 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Bms Strategic Portfolio Investments Holdings, Inc.

United States Of America

Active
Notified 17 Oct 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Oxford Science Enterprises Plc

Ceased 17 Oct 2022

Ceased

Evotec International Gmbh

Ceased 28 Jun 2024

Ceased

Andrew James Mclean

Ceased 24 Jul 2020

Ceased
See All Controllers

Group Structure

Group Structure

BMS STRATEGIC PORTFOLIO INVESTMENTS HOLDINGS, INC. united states of america
OXFORD SCIENCE ENTERPRISES PLC united kingdom
DARK BLUE THERAPEUTICS LTD Current Company
KLEIDOX THERAPEUTICS LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
SANDYMOUNT THERAPEUTICS LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
28 Oct 2025ResolutionResolutionsView(1 page)
5 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-03 with updatesView(6 pages)
30 Apr 2025CapitalAllotment of shares (GBP 11,986.719) on 2025-04-28View(4 pages)
2 Apr 2025OfficersAppointment of Dr Edwin Moses as director on 2025-03-17View(2 pages)
6 Mar 2025CapitalAllotment of shares (GBP 11,696.851) on 2025-03-06View(4 pages)
28 Oct 2025 Resolution

Resolutions

View Document(1 page)
5 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-03 with updates

View Document(6 pages)
30 Apr 2025 Capital

Allotment of shares (GBP 11,986.719) on 2025-04-28

View Document(4 pages)
2 Apr 2025 Officers

Appointment of Dr Edwin Moses as director on 2025-03-17

View Document(2 pages)
6 Mar 2025 Capital

Allotment of shares (GBP 11,696.851) on 2025-03-06

View Document(4 pages)

Recent Activity

Latest Activity

Resolutions

3 months ago on 28 Oct 2025

Confirmation statement made on 2025-06-03 with updates

8 months ago on 5 Jun 2025

Allotment of shares (GBP 11,986.719) on 2025-04-28

9 months ago on 30 Apr 2025

Appointment of Dr Edwin Moses as director on 2025-03-17

10 months ago on 2 Apr 2025

Allotment of shares (GBP 11,696.851) on 2025-03-06

11 months ago on 6 Mar 2025